Diagnosis of Overtraining Syndrome: Results of the Endocrine and Metabolic Responses on Overtraining Syndrome Study: EROS-DIAGNOSIS

Flavio Adsuara Cadegiani, Pedro Henrique Luiz da Silva, Tatiana Camargo Pereira Abrao, Claudio Elias Kater, Flavio Adsuara Cadegiani, Pedro Henrique Luiz da Silva, Tatiana Camargo Pereira Abrao, Claudio Elias Kater

Abstract

Objectives: Overtraining syndrome (OTS), a common dysfunction among elite athletes, causes decreased performance and fatigue and has no standardized diagnostic criteria. The Endocrine and Metabolic Responses on Overtraining Syndrome (EROS) study identified more than 45 potential biomarkers of OTS. In the present study, we hypothesized that combinations of these biomarkers could be an accurate diagnostic tool for OTS.

Methods: We selected parameters with largest difference and fewest overlapping results compared to healthy athletes and highest feasibility and reproducibility. Among the multiple combinations attempted, we chose those that did not show overlapping results, according to the objective.

Results: We included 11 clinical parameters, 4 basal hormones, and 5 hormonal responses in Insulin Tolerance Test (ITT). The three selected diagnostic tools were the (i) EROS-CLINICAL, with only clinical parameters, which was suitable as an initial assessment for athletes suspected of OTS; (ii) EROS-SIMPLIFIED, with clinical parameters and basal hormones, when the EROS-CLINICAL was inconclusive; and (iii) EROS-COMPLETE, with basal and hormonal responses to stimulation tests, which was valuable for population-based screening, research purposes, and unusual presentations of OTS.

Conclusion: We identified innovative tools with 100% accuracy for the diagnosis of OTS, without the need to exclude confounding disorders.

Conflict of interest statement

The authors declare no conflicts of interest regarding the publication of this paper.

Copyright © 2020 Flavio Adsuara Cadegiani et al.

Figures

Figure 1
Figure 1
Sequence of steps for the identification of the most appropriate markers for the EROS tools.
Figure 2
Figure 2
Selection process for choosing parameters for the proposed tools.
Figure 3
Figure 3
Flowchart for choosing the most suitable tool for use in clinical practice.
Figure 4
Figure 4
Flowchart for the choice of the most appropriate score to be used in each athlete.

References

    1. Meeusen R., Duclos M., Foster C., et al. Prevention, diagnosis, and treatment of the overtraining syndrome: joint consensus statement of the European College of Sport Science and the American College of Sports Medicine. Medicine & Science in Sports & Exercise. 2013;45(1):186–205.
    1. Kreher J. B., Schwartz J. B. Overtraining syndrome. Sports Health: A Multidisciplinary Approach. 2012;4(2):128–138. doi: 10.1177/1941738111434406.
    1. Lehman M., Foster C., Keul J. Overtraining in endurance athletes: a brief review. Medicine & Science in Sports & Exercise. 1993;25(7):854–862. doi: 10.1249/00005768-199307000-00015.
    1. Rietjens G. J. W. M., Kuipers H., Adam J. J., et al. Physiological, biochemical and psychological markers of strenuous training-induced fatigue. International Journal of Sports Medicine. 2005;26(01/02):16–26. doi: 10.1055/s-2004-817914.
    1. Kreider R., Fry A. C., O’Toole M. Overtraining in sport: terms, definitions, and prevalence. In: Kreider R., Fry A. C., O’Toole M., editors. Overtraining in Sport. Champaign, IL, USA: Human Kinetics; 1998.
    1. Nederhof E., Zwerver J., Brink M., Meeusen R., Lemmink K. Different diagnostic tools in nonfunctional overreaching. International Journal of Sports Medicine. 2008;29(7):590–597. doi: 10.1055/s-2007-989264.
    1. Cadegiani F. A., Kater C. E. Hormonal aspects of overtraining syndrome: a systematic review. BMC Sports Science, Medicine and Rehabilitation. 2017;9:p. 14. doi: 10.1186/s13102-017-0079-8.
    1. Cadegiani F. A., Kater C. E. Hypothalamic-pituitary-adrenal (HPA) axis functioning in overtraining syndrome: findings from endocrine and metabolic responses on overtraining syndrome (EROS)-EROS-HPA Axis. Sports Medicine Open. 2017;3(1):p. 45. doi: 10.1186/s40798-017-0113-0.
    1. Cadegiani F. A., Kater C. E. Hormonal response to a non-exercise stress test in athletes with overtraining syndrome: results from the endocrine and metabolic responses on overtraining syndrome (EROS)-EROS-STRESS. Journal of Science and Medicine in Sport. 2018 Jul;21(7):648–653. doi: 10.1016/j.jsams.2017.10.033.
    1. Cadegiani F. A., Kater C. E. Body composition, metabolism, sleep, psychological and eating patterns of overtraining syndrome: results of the EROS study (EROS-PROFILE) Journal of Sports Sciences. 2018;36(16):1902–1910. doi: 10.1080/02640414.2018.1424498.
    1. Cadegiani F. A., Kater C. E. Basal hormones and biochemical markers as predictors of overtraining syndrome in male athletes: the EROS-BASAL study. Journal of Athletic Training. 2019;54(8):906–914. doi: 10.4085/1062-6050-148-18.
    1. Cadegiani F. A., Kater C. E. Inter-correlations among clinical, metabolic, and biochemical parameters and their predictive value in healthy and overtrained male athletes: the EROS-CORRELATIONS study. Frontiers in Endocrinology. 2019;10 doi: 10.3389/fendo.2019.00858.
    1. Cadegiani F. A., Kater C. E. Novel causes and consequences of overtraining syndrome: the EROS-DISRUPTORS study. BMC Sports Science, Medicine and Rehabilitation. 2019;11(1):p. 21. doi: 10.1186/s13102-019-0132-x.
    1. Cadegiani F. A., Kater C. E. Novel insights of overtraining syndrome discovered from the EROS study. BMJ Open Sport & Exercise Medicine. 2019;5(1) doi: 10.1136/bmjsem-2019-000542.e000542

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere